Technology
Health
Biotechnology

HTG Molecular

$1.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.04 (-2.68%) Today
+$0.01 (0.69%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell HTG Molecular and other stocks, options, ETFs, and crypto commission-free!

About HTGM

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. Its customers include biopharmaceutical companies, academic research centers, and molecular testing laboratories. Read More The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ.

Employees
107
Headquarters
Tucson, Arizona
Founded
1997
Market Cap
42.64M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
237.70K
High Today
$1.55
Low Today
$1.43
Open Price
$1.50
Volume
210.25K
52 Week High
$5.46
52 Week Low
$1.43

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2015 IPO
US
North America

HTGM Earnings

-$0.31
-$0.23
-$0.15
-$0.07
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.